Research location
Orbassano
Italy
Advertisement
Research activity in Orbassano
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 157 trials and 158 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Orbassano
157 linked trials · page 2 of 4Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)NCT04644237 · 2021-03-19 · 1 site observation
COMPLETED
Study on Patterns of Care in Mild Asthmatic PatientsNCT04598555 · 2021-02-25 · 1 site observation
COMPLETED
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerNCT04612751 · 2021-02-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)NCT04656652 · 2020-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerNCT04351555 · 2020-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.NCT04642469 · 2020-11-30 · 1 site observation
COMPLETED
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT04487080 · 2020-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)NCT04497844 · 2020-09-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)NCT04385368 · 2020-07-17 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in ItalyNCT04463108 · 2020-06-23 · 1 site observation
COMPLETED
COVID19-hematological Malignancies: the Italian Hematology AllianceNCT04352556 · 2020-04-07 · 1 site observation
UNKNOWN
Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)NCT03896074 · 2020-03-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerNCT04100018 · 2020-02-06 · 1 site observation
COMPLETED
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)NCT04934800 · 2019-12-10 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical PracticeNCT04094415 · 2019-10-28 · 1 site observation
COMPLETED
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation
COMPLETED
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)NCT03944772 · 2019-06-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple SclerosisNCT03926637 · 2019-06-17 · 1 site observation
TERMINATED
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyNCT03767244 · 2019-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung CancerNCT03794544 · 2019-03-08 · 1 site observation
COMPLETED
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationNCT03833154 · 2019-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibNCT03778229 · 2019-01-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeNCT03697109 · 2018-11-15 · 1 site observation
COMPLETED
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerNCT03732820 · 2018-10-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT03703297 · 2018-09-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Pembrolizumab in Untreated Extensive SCLCNCT02580994 · 2017-12-08 · 1 site observation
COMPLETED
Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - ItalyNCT03003494 · 2017-06-06 · 1 site observation
COMPLETED
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)NCT03061812 · 2017-04-11 · 1 site observation
COMPLETED
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.NCT02933801 · 2017-03-31 · 1 site observation
TERMINATED
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)NCT02907177 · 2017-03-30 · 1 site observation
TERMINATED
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)NCT03033511 · 2017-02-07 · 1 site observation
TERMINATED
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in ItalyNCT03005769 · 2016-12-01 · 1 site observation
COMPLETED
Study to Evaluate CORT125134 in Participants With Cushing's SyndromeNCT02804750 · 2016-06-01 · 1 site observation
COMPLETED
Plegridy Satisfaction Study in ParticipantsNCT02587065 · 2016-02-03 · 1 site observation
COMPLETED
SATisfaction and Adherence to COPD TreatmentNCT02689492 · 2015-12-11 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)NCT02357147 · 2015-11-03 · 1 site observation
TERMINATED
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.NCT02511106 · 2015-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseNCT02419872 · 2015-05-31 · 1 site observation
COMPLETED
A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerNCT02352948 · 2015-01-13 · 1 site observation
COMPLETED
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboNCT02284568 · 2015-01-12 · 1 site observation
COMPLETED
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerNCT02296125 · 2014-12-03 · 1 site observation
COMPLETED
LUMINIST: LUng Cancer Molecular Insights Non Interventional StudyNCT02300831 · 2014-12-01 · 1 site observation
COMPLETED
A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate CancerNCT02293707 · 2014-11-01 · 1 site observation
COMPLETED
AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT02151981 · 2014-08-04 · 1 site observation
COMPLETED
Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02138916 · 2014-06-13 · 1 site observation
COMPLETED
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)NCT02038647 · 2014-05-12 · 1 site observation
COMPLETED
Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012NCT02579681 · 2014-04-30 · 1 site observation
COMPLETED
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT02106546 · 2014-04-10 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.